CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Sonic Healthcare Limited - SHLau CFD

29.283
0.79%
Market Trading Hours* (UTC) Opens on Monday at 00:00

Mon - Thu: 00:00 - 05:00 23:05 - 00:00

Fri: 00:00 - 05:00

Sun: 23:05 - 00:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.124
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.02273 %
Charges from full value of position ($-4.32)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02273%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.000812 %
Charges from full value of position ($0.15)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.000812%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency AUD
Margin 5%
Stock exchange Australia
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 29.063
Open* 28.764
1-Year Change* -12.24%
Day's Range* 28.644 - 29.313
52 wk Range 29.37-46.95
Average Volume (10 days) 1.03M
Average Volume (3 months) 23.44M
Market Cap 15.48B
P/E Ratio 10.65
Shares Outstanding 471.64M
Revenue 9.34B
EPS 3.02
Dividend (Yield %) 3.10463
Beta 0.86
Next Earnings Date Feb 20, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 23, 2024 29.283 0.210 0.72% 29.073 29.363 29.063
Feb 22, 2024 29.073 0.305 1.06% 28.768 29.093 28.624
Feb 21, 2024 28.774 0.060 0.21% 28.714 29.193 28.534
Feb 20, 2024 28.704 -0.579 -1.98% 29.283 29.622 28.045
Feb 19, 2024 29.273 -2.475 -7.80% 31.748 31.948 29.273
Feb 18, 2024 31.748 -0.240 -0.75% 31.988 32.008 31.598
Feb 16, 2024 31.918 -0.050 -0.16% 31.968 32.207 31.738
Feb 15, 2024 31.958 -0.269 -0.83% 32.227 32.327 31.768
Feb 14, 2024 32.207 0.369 1.16% 31.838 32.506 31.718
Feb 13, 2024 31.838 -0.439 -1.36% 32.277 32.417 31.648
Feb 12, 2024 32.277 0.549 1.73% 31.728 32.357 31.678
Feb 11, 2024 31.728 -0.010 -0.03% 31.738 31.898 31.658
Feb 9, 2024 31.738 0.100 0.32% 31.638 31.748 31.479
Feb 8, 2024 31.618 0.169 0.54% 31.449 31.728 31.179
Feb 7, 2024 31.439 -0.069 -0.22% 31.508 31.588 31.069
Feb 6, 2024 31.508 0.059 0.19% 31.449 31.613 31.259
Feb 5, 2024 31.439 -0.239 -0.75% 31.678 32.107 31.439
Feb 4, 2024 31.678 0.020 0.06% 31.658 31.808 31.618
Feb 2, 2024 31.718 -0.050 -0.16% 31.768 31.958 31.638
Feb 1, 2024 31.758 -0.160 -0.50% 31.918 31.967 31.479

Sonic Healthcare Limited Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 8168.95 9340.15 8754.12 6831.84 6133.67
Revenue 8168.95 9340.15 8754.12 6831.84 6133.67
Cost of Revenue, Total 1279.69 1604.46 1616.83 1117.37 995.288
Gross Profit 6889.25 7735.69 7137.29 5714.47 5138.38
Total Operating Expense 7150.73 7183.13 6833.01 6019.93 5325.35
Selling/General/Admin. Expenses, Total 4263.85 4280.21 3958.81 3744.34 3666.74
Depreciation / Amortization 702.928 675.417 641.594 605.868 273.144
Unusual Expense (Income) 0.883 3.348 0.62 2.134 -42.518
Other Operating Expenses, Total 903.376 619.698 615.155 550.213 432.697
Operating Income 1018.21 2157.02 1921.11 811.914 808.32
Interest Income (Expense), Net Non-Operating -87.025 -79.819 -92.519 -112.851 -86.063
Net Income Before Taxes 931.188 2077.21 1828.59 699.063 722.257
Net Income After Taxes 707.931 1515.47 1347.66 541.903 559.069
Minority Interest -22.947 -54.9 -32.618 -14.154 -9.344
Net Income Before Extra. Items 684.984 1460.57 1315.04 527.749 549.725
Net Income 684.984 1460.57 1315.04 527.749 549.725
Income Available to Common Excl. Extra. Items 684.984 1460.57 1315.04 527.749 549.725
Income Available to Common Incl. Extra. Items 684.984 1460.57 1315.04 527.749 549.725
Diluted Net Income 684.984 1460.57 1315.04 527.749 549.725
Diluted Weighted Average Shares 472.444 482.88 481.461 477.161 450.309
Diluted EPS Excluding Extraordinary Items 1.44987 3.0247 2.73135 1.10602 1.22077
Dividends per Share - Common Stock Primary Issue 1.04 1 0.91 0.85 0.84
Diluted Normalized EPS 1.4513 3.02976 2.74009 1.13373 1.20655
Total Extraordinary Items 0
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total revenue 4086.71 4082.24 4583.62 4756.53 4321.89
Revenue 4086.71 4082.24 4583.62 4756.53 4321.89
Cost of Revenue, Total 657.22 622.475 793.492 810.967 786.136
Gross Profit 3429.49 3459.76 3790.13 3945.56 3535.75
Total Operating Expense 3647.49 3503.24 3635.37 3547.76 3396.14
Selling/General/Admin. Expenses, Total 2158.35 2105.5 2209.71 2070.5 1999.94
Depreciation / Amortization 357.31 345.618 343.809 331.608 328.504
Other Operating Expenses, Total 474.608 429.651 288.363 334.683 281.558
Operating Income 439.222 578.991 948.255 1208.77 925.752
Interest Income (Expense), Net Non-Operating -44.94 -42.085 -39.544 -40.275 -41.167
Net Income Before Taxes 394.282 536.906 908.711 1168.49 884.585
Net Income After Taxes 315.648 392.283 665.99 849.476 658.246
Minority Interest -13.018 -9.929 -33.089 -21.811 -20.841
Net Income Before Extra. Items 302.63 382.354 632.901 827.665 637.405
Net Income 302.63 382.354 632.901 827.665 637.405
Income Available to Common Excl. Extra. Items 302.63 382.354 632.901 827.665 637.405
Income Available to Common Incl. Extra. Items 302.63 382.354 632.901 827.665 637.405
Dilution Adjustment
Diluted Net Income 302.63 382.354 632.901 827.665 637.405
Diluted Weighted Average Shares 472.077 472.81 481.179 484.581 481.987
Diluted EPS Excluding Extraordinary Items 0.64106 0.80868 1.31531 1.708 1.32245
Dividends per Share - Common Stock Primary Issue 0.62 0.42 0.6 0.4 0.55
Diluted Normalized EPS 0.64106 0.80868 1.31531 1.708 1.33031
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 2133.17 2305.91 2284.57 2455.1 1753.18
Cash and Short Term Investments 797.994 779.997 899.827 1230.15 736.646
Cash 797.994 779.997 899.827 1230.15 736.646
Total Receivables, Net 1022.17 1217.46 1088.72 986.77 827.932
Accounts Receivable - Trade, Net 904.462 1087.3 989.976 868.626 725.386
Total Inventory 199.201 216.193 224.388 163.425 119.673
Prepaid Expenses 113.801 92.258 71.641 74.761 68.933
Total Assets 13014.6 12552 11761 12127.1 9959.83
Property/Plant/Equipment, Total - Net 2798.11 2624.86 2552.92 2498.08 1268.32
Property/Plant/Equipment, Total - Gross 5199.61 4735.31 4460.72 4260.16 2940.44
Accumulated Depreciation, Total -2401.51 -2110.45 -1907.8 -1762.08 -1672.12
Goodwill, Net 7237.43 6852.96 6231.85 6486.33 6320.73
Intangibles, Net 552.19 508.524 480.404 468.57 444.008
Long Term Investments 175.799 145.222 108.11 91.754 88.135
Note Receivable - Long Term 37.739 38.191 31.549 50.429 40.201
Other Long Term Assets, Total 80.195 76.34 71.584 76.858 45.257
Total Current Liabilities 1878.34 2084.27 2217.94 2070.13 1849.38
Accounts Payable 255.799 243.8 225.262 362.027 229.67
Accrued Expenses 342.608 328.166 302.538 259.826 221.068
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 346.791 341.858 551.431 663.121 826.004
Other Current Liabilities, Total 933.145 1170.45 1138.71 785.159 572.642
Total Liabilities 5278.12 5278.87 5376 6553.38 4547.5
Total Long Term Debt 2753.69 2670.88 2683.38 3952.76 2209.59
Long Term Debt 1673.46 1576.93 1592.38 2872.43 2207.88
Capital Lease Obligations 1080.23 1093.94 1091 1080.33 1.711
Deferred Income Tax 332.731 264.24 190.505 173.335 151.116
Minority Interest 185.358 155.034 119.357 90.645 79.536
Other Liabilities, Total 128.004 104.446 164.826 266.504 257.873
Total Equity 7736.5 7273.14 6384.99 5573.75 5412.33
Common Stock 3842.42 3866.85 4082.12 4001.06 3967.1
Retained Earnings (Accumulated Deficit) 3413.13 3241.95 2228.86 1318.28 1225.15
Treasury Stock - Common 0 -5.902 -0.14 -0.147 -0.209
Unrealized Gain (Loss) 5.193 3.272 3.272 3.272 3.272
Other Equity, Total 475.76 166.967 70.871 251.294 217.016
Total Liabilities & Shareholders’ Equity 13014.6 12552 11761 12127.1 9959.83
Total Common Shares Outstanding 470.806 471.637 477.919 475.176 473.948
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total Current Assets 2133.17 2028.97 2305.91 2363.84 2284.57
Cash and Short Term Investments 797.994 730.772 779.997 735.329 899.827
Cash 797.994 730.772 779.997 735.329 899.827
Total Receivables, Net 1022.17 975.365 1217.46 1284.74 1088.72
Accounts Receivable - Trade, Net 1022.17 975.365 1217.46 1284.74 1088.72
Total Inventory 199.201 214.325 216.193 257.723 224.388
Other Current Assets, Total
Total Assets 13014.6 12536.4 12552 12464.2 11761
Property/Plant/Equipment, Total - Net 2798.11 2661.81 2624.86 2580.42 2552.92
Goodwill, Net 7237.43 7035.06 6852.96 6721.25 6231.85
Intangibles, Net 552.19 529.015 508.524 491.093 480.404
Long Term Investments 175.799 163.699 145.222 191.613 108.11
Note Receivable - Long Term 37.739 38.594 38.191 36.876 31.549
Other Long Term Assets, Total 80.195 79.272 76.34 79.104 71.584
Total Current Liabilities 1878.34 1866.5 2084.27 1997.42 2217.94
Accounts Payable 959.992 920.991 1018.55 1020.97 1026.54
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 346.791 341.862 341.858 337.569 551.431
Other Current Liabilities, Total 571.56 603.651 723.864 638.876 639.971
Total Liabilities 5278.12 5142.56 5278.87 5410.33 5376
Total Long Term Debt 2753.69 2691.32 2670.88 2880.66 2683.38
Long Term Debt 1673.46 1619.64 1576.93 1789.46 1592.38
Capital Lease Obligations 1080.23 1071.68 1093.94 1091.2 1091
Deferred Income Tax 332.731 299.485 264.24 241.502 190.505
Minority Interest 185.358 163.822 155.034 138.79 119.357
Other Liabilities, Total 128.004 121.425 104.446 151.961 164.826
Total Equity 7736.5 7393.86 7273.14 7053.86 6384.99
Common Stock 3842.42 3760.06 3866.85 4144.01 4082.12
Retained Earnings (Accumulated Deficit) 3413.13 3329.7 3241.95 2781.15 2228.86
Treasury Stock - Common 0 -2.118 -5.902 -8.411 -0.14
Unrealized Gain (Loss) 5.193 6.777 3.272 3.272 3.272
Other Equity, Total 475.76 299.438 166.967 133.842 70.871
Total Liabilities & Shareholders’ Equity 13014.6 12536.4 12552 12464.2 11761
Total Common Shares Outstanding 470.806 468.264 471.637 479.517 477.919
Prepaid Expenses 113.801 108.505 92.258 86.044 71.641
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Cash From Operating Activities 2225.82 2042.84 1360.3 847.308 767.92
Cash Receipts 9423.32 8808.46 6801.35 6258.44 5641.61
Cash Payments -6744.34 -6323.48 -5209.42 -5207.53 -4713.56
Cash Taxes Paid -378.188 -342.219 -136.413 -126.303 -89.332
Cash Interest Paid -76.96 -102.842 -101.17 -83.93 -73.969
Changes in Working Capital 1.994 2.916 5.947 6.636 3.175
Cash From Investing Activities -989.18 -386.75 -334.917 -1099.33 -464.436
Capital Expenditures -378.589 -363.192 -333.092 -386.648 -327.623
Other Investing Cash Flow Items, Total -610.591 -23.558 -1.825 -712.681 -136.813
Cash From Financing Activities -1349.29 -1954.66 -536.736 687.666 -433.419
Financing Cash Flow Items -15.472 -10.719 -8.663 -8.611 -6.857
Total Cash Dividends Paid -455.397 -415.513 -403.667 -365.112 -233.673
Issuance (Retirement) of Stock, Net -253.733 53.633 22.997 943.975 15.427
Issuance (Retirement) of Debt, Net -624.692 -1582.06 -147.403 117.414 -208.316
Foreign Exchange Effects -7.177 -31.75 4.858 -12.267 5.586
Net Change in Cash -119.83 -330.322 493.503 423.378 -124.349
Dec 2022 Jun 2022 Dec 2021 Jun 2021 Dec 2020
Cash From Operating Activities 785.272 2225.82 1040.64 2042.84 810.478
Cash Receipts 4463.68 9423.32 4704.53 8808.46 4372
Cash Payments -3395.91 -6744.34 -3398.64 -6323.48 -3286.88
Cash Taxes Paid -246.523 -378.188 -227.494 -342.219 -221.771
Cash Interest Paid -40.395 -76.96 -38.506 -102.842 -54.472
Changes in Working Capital 4.418 1.994 0.742 2.916 1.596
Cash From Investing Activities -258.086 -989.18 -755.817 -386.75 -208.331
Capital Expenditures -221.322 -378.589 -174.583 -363.192 -187.201
Other Investing Cash Flow Items, Total -36.764 -610.591 -581.234 -23.558 -21.13
Cash From Financing Activities -584.548 -1349.29 -462.128 -1954.66 -931.055
Financing Cash Flow Items -4.308 -15.472 -3.926 -10.719 -4.65
Total Cash Dividends Paid -283.382 -455.397 -263.441 -415.513 -243.488
Issuance (Retirement) of Stock, Net -112.383 -253.733 31.86 53.633 51.413
Issuance (Retirement) of Debt, Net -184.475 -624.692 -226.621 -1582.06 -734.33
Foreign Exchange Effects 8.137 -7.177 12.806 -31.75 -44.4
Net Change in Cash -49.225 -119.83 -164.498 -330.322 -373.308
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 5.0714 24058158 18414 2023-09-08 LOW
State Street Global Advisors Australia Ltd. Investment Advisor/Hedge Fund 3.8068 18058834 0 2023-09-08 LOW
Jardvan Pty. Ltd. Corporation 3.185 15109474 0 2023-09-08 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.9556 14021044 0 2023-09-08 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.8091 8582102 1368494 2022-12-31 LOW
Vanguard Investments Australia Ltd. Investment Advisor 1.4752 6998287 76749 2023-09-30 LOW
Veritas Asset Management LLP Investment Advisor/Hedge Fund 1.2923 6130641 0 2023-09-30 LOW
Guinness Atkinson Asset Management Inc. Investment Advisor 1.287 6105517 4311 2023-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.2752 6049291 0 2023-09-08 LOW
BlackRock Investment Management (Australia) Ltd. Investment Advisor 1.0758 5103717 0 2023-09-08 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.8694 4124427 0 2023-09-08 LOW
Argo Investments Limited Investment Advisor 0.7854 3726053 0 2023-09-08 LOW
Baillie Gifford & Co. Investment Advisor 0.7853 3725574 0 2023-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7314 3469841 4738 2023-09-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.6845 3247227 218894 2023-09-30 LOW
Australian Foundation Investment Company Ltd Investment Advisor 0.666 3159672 0 2023-09-08 LOW
Netwealth Investments Ltd. Investment Advisor 0.6347 3011026 140750 2023-09-08 LOW
Sarasin & Partners LLP Investment Advisor 0.5848 2774440 0 2023-09-30 LOW
Deka Investment GmbH Investment Advisor/Hedge Fund 0.5731 2718857 311 2023-09-30 LOW
BetaShares Capital Ltd. Investment Advisor 0.5402 2562538 -11041 2023-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Sonic Healthcare Limited Company profile

Sonic Healthcare Limited
Industry: Medical & Diagnostic Laboratories

Level 22, 225 George Street
SYDNEY
NEW SOUTH WALES 2000
AU

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

BTC/USD

51,129.45 Price
+0.160% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,035.76 Price
+0.560% 1D Chg, %
Long position overnight fee -0.0185%
Short position overnight fee 0.0103%
Overnight fee time 22:00 (UTC)
Spread 0.50

Oil - Crude

76.56 Price
-2.240% 1D Chg, %
Long position overnight fee 0.0163%
Short position overnight fee -0.0382%
Overnight fee time 22:00 (UTC)
Spread 0.030

US100

17,914.30 Price
-0.300% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading